Literature DB >> 17613848

Community visual field screening: prevalence of follow-up and factors associated with follow-up of participants with abnormal frequency doubling perimetry technology results.

Steven L Mansberger1, Beth Edmunds, Chris A Johnson, Kyle J Kent, George A Cioffi.   

Abstract

PURPOSE: To determine if a community screening with Frequency Doubling Technology perimetry (FDT) results in a high proportion of follow-up with an eye care provider and the factors associated with follow-up.
DESIGN: Cross-sectional study.
SETTING: Telephone survey
METHODS: We conducted a telephone survey of participants with abnormal results 3-6 months after the community screening.
RESULTS: We were able to interview 121 participants (57% of 212 eligible subjects). Sixty-nine percent (83 of 121) of participants visited an eye care provider after the screening. Patients were more likely to attain an eye exam if they were female, older, or had an educational level of high school or more (p<0.05). Of those participants who did not visit an eye care provider, 41% (18/38) did not believe the results of the test, 21% (8/38) reported not having insurance or an eye care provider, 11% (4/38) did not have time for an eye exam, and 11% (4/38) reported not knowing they needed to see an eye care provider.
CONCLUSION: A community screening program with FDT encouraged more than two thirds of participants with abnormal results to seek an eye exam. The most common reason not to attain an eye exam was failing to recognize the importance of an abnormal test result.

Entities:  

Mesh:

Year:  2007        PMID: 17613848     DOI: 10.1080/09286580601174060

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  11 in total

1.  Community-based vision health screening with on-site definitive exams: Design and outcomes.

Authors:  Mitch Brinks; Tosha Zaback; Dong-Wouk Park; Randall Joan; Stephanie K Cramer; Michael F Chiang
Journal:  Cogent Med       Date:  2018-12-18

2.  A comparative effectiveness analysis of visual field outcomes after projected glaucoma screening using SD-OCT in African American communities.

Authors:  Dana M Blumberg; Reena Vaswani; Eva Nong; Lama Al-Aswad; George A Cioffi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-01       Impact factor: 4.799

3.  Providing prescheduled appointments as a strategy for improving follow-up compliance after community-based glaucoma screening: results from an urban underserved population.

Authors:  Tavé van Zyl; Zhuo Su; Elaine Zhou; Ryan K Wong; Amir Mohsenin; Spencer Rogers; James C Tsai; Susan H Forster
Journal:  J Community Health       Date:  2015-02

4.  Predictive value of screening tests for visually significant eye disease.

Authors:  Laura J Kopplin; Steven L Mansberger
Journal:  Am J Ophthalmol       Date:  2015-06-04       Impact factor: 5.258

5.  Glaucoma public service announcements: factors associated with follow-up of participants with risk factors for glaucoma.

Authors:  Zakary Hoffelt; Shawn Fallon; Brad A Wong; Betty Lucas; Anne L Coleman; Richard P Mills; Richard Wilson; Steven L Mansberger
Journal:  Ophthalmology       Date:  2011-03-24       Impact factor: 12.079

6.  Barriers to Receiving Follow-Up Eye Care and Detection of Non-Glaucomatous Ocular Pathology in the Philadelphia Glaucoma Detection and Treatment Project.

Authors:  Cindy X Zheng; Wanda D Hu; Judie Tran; Linda Siam; Giuliana G Berardi; Harjeet Sembhi; Lisa A Hark; L Jay Katz; Michael Waisbourd
Journal:  J Community Health       Date:  2016-04

7.  Features of optic disc progression in patients with ocular hypertension and early glaucoma.

Authors:  Michael J Lloyd; Steven L Mansberger; Brad A Fortune; Hau Nguyen; Rodrigo Torres; Shaban Demirel; Stuart K Gardiner; Chris A Johnson; George A Cioffi
Journal:  J Glaucoma       Date:  2013 Jun-Jul       Impact factor: 2.503

8.  Assessment of patient opinions of different clinical tests used in the management of glaucoma.

Authors:  Stuart K Gardiner; Shaban Demirel
Journal:  Ophthalmology       Date:  2008-12       Impact factor: 12.079

Review 9.  Diagnostic tools for glaucoma detection and management.

Authors:  Pooja Sharma; Pamela A Sample; Linda M Zangwill; Joel S Schuman
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

10.  Alzheimer's disease: screening biomarkers using frequency doubling technology visual field.

Authors:  Denise A Valenti
Journal:  ISRN Neurol       Date:  2013-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.